Geographical disparities and temporal trends of end stage kidney disease incidence: a systematic review

While individual studies address the geographical and temporal variations contributing to end-stage kidney disease (ESKD) incidence, there is a notable lack of comprehensive research consolidating these findings. This study systematically reviewed and analyzed original articles reporting the incidence of ESKD across different geographical locations and time over two decades worldwide. The study focused on individuals with ESKD, aged 18 and older, regardless of whether they received kidney replacement therapy. Original studies published between 01 Jan 2003 and 23 March 2026 focusing on ESKD incidence and reporting geographical variations and/or temporal trends were included. Literature screening and data extraction were performed using Covidence. Geographical variations in ESKD incidence were assessed across countries, major sub-divisions, and small areas, while temporal trends were evaluated both annually and seasonally. Among forty-one papers reviewed, 18 (43.9%) reported geographical variation, 17 (41.5%) reported temporal trends, and 6(14.6%) reported both. Of those examining geographical variations, 16.7% assessed ESKD incidence across countries, 33.3% across major sub-divisions, and 50.0% across small areas. ESKD incidence varies widely across regions, ranging from 100 per million population in Nepal to over 450 in Taiwan, with higher rates in high-income settings and notable within-country disparities in areas such as the southern United States, southern Taiwan, and parts of Japan. Incidence has increased over time, though some regions remain stable, with higher rates observed in winter than summer. Geographical variation in ESKD incidence was observed across countries, regions, and small areas, with notable increases over time. Factors impacting geographical variations include angiotensin converting enzyme inhibitor use, income, erythropoietin use, obesity, and paraquat exposure, while race, country of residence, diabetes type, hypertension, cardiovascular disease, and calendar year affect temporal variations. Both age and gender contribute to geographical and temporal variations.

Authors

Institutions

Publication Details

Journal
BMC Public Health
Published
2026-07-28
DOI
https://doi.org/10.1186/s12889-026-28365-2
Primary Topic
Chronic Kidney Disease and Diabetes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Geographical disparities and temporal trends of end stage kidney disease incidence: a systematic review

Darsy Darssan, Nicholas J. Osborne, Gail M. Williams, Yohani Dalugoda et al.
BMC Public Health
Chronic Kidney Disease and Diabetes
article

Geographical disparities and temporal trends of end stage kidney disease incidence: a systematic review

Darsy Darssan, Nicholas J. Osborne, Gail M. Williams, Yohani Dalugoda, Mark K. Tiong, Lijalem M. Tesfaw
article en

Abstract

While individual studies address the geographical and temporal variations contributing to end-stage kidney disease (ESKD) incidence, there is a notable lack of comprehensive research consolidating these findings. This study systematically reviewed and analyzed original articles reporting the incidence of ESKD across different geographical locations and time over two decades worldwide. The study focused on individuals with ESKD, aged 18 and older, regardless of whether they received kidney replacement therapy. Original studies published between 01 Jan 2003 and 23 March 2026 focusing on ESKD incidence and reporting geographical variations and/or temporal trends were included. Literature screening and data extraction were performed using Covidence. Geographical variations in ESKD incidence were assessed across countries, major sub-divisions, and small areas, while temporal trends were evaluated both annually and seasonally. Among forty-one papers reviewed, 18 (43.9%) reported geographical variation, 17 (41.5%) reported temporal trends, and 6(14.6%) reported both. Of those examining geographical variations, 16.7% assessed ESKD incidence across countries, 33.3% across major sub-divisions, and 50.0% across small areas. ESKD incidence varies widely across regions, ranging from 100 per million population in Nepal to over 450 in Taiwan, with higher rates in high-income settings and notable within-country disparities in areas such as the southern United States, southern Taiwan, and parts of Japan. Incidence has increased over time, though some regions remain stable, with higher rates observed in winter than summer. Geographical variation in ESKD incidence was observed across countries, regions, and small areas, with notable increases over time. Factors impacting geographical variations include angiotensin converting enzyme inhibitor use, income, erythropoietin use, obesity, and paraquat exposure, while race, country of residence, diabetes type, hypertension, cardiovascular disease, and calendar year affect temporal variations. Both age and gender contribute to geographical and temporal variations.

BMC Public Health
The Royal Melbourne Hospital (AU), The University of Queensland (AU), The University of Melbourne (AU), Royal Cornwall Hospital (GB), UNSW Sydney (AU), Bahir Dar University (ET)
No poverty
Openalex Percentile: Top 9%
Chronic Kidney Disease and Diabetes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.